This site is intended for health professionals only

Editor’s pick

Denosumab for menopausal and cancer-related bone loss
Patient knowledge of colorectal cancer therapy side-effects
Patient knowledge of colorectal cancer therapy side-effects
Understanding compassionate-use programmes
Understanding compassionate-use programmes
ECCMID: Developments in invasive fungal disease
ECCMID: Developments in invasive fungal disease
ECCO President’s preview of the Congress
ECCO President’s preview of the Congress
‘No improvement’ in pancreatic cancer survival
‘No improvement’ in pancreatic cancer survival
Schizophrenia substance set for FDA review
Schizophrenia substance set for FDA review
Cancer patients ‘living six times longer’
Cancer patients ‘living six times longer’
FDA revokes breast cancer indication for Avastin
FDA revokes breast cancer indication for Avastin
CAPRELSA given CHMP vote for thyroid cancer
CAPRELSA given CHMP vote for thyroid cancer
New class of dual-acting antimalarials found
New class of dual-acting antimalarials found
NICE refuses to fund breast cancer drug
NICE refuses to fund breast cancer drug
1 2 3 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x